Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB26FQTL0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,824
Award facts
- Contract value 100% obligated
- $20,824.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a Delivery Order valued at $20,824.26 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Dupixent 200 mg/1.14 mL pen injectors. This firm fixed-price, competitively awarded contract (no set-aside) is scheduled for completion by November 7, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic immunosuppressant used to treat moderate-to-severe eczema, asthma, and chronic rhinosinusitis, making it a critical pharmaceutical commodity for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a primary vendor for federal medical procurement, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical devices to support military healthcare programs worldwide. The company's contract portfolio demonstrates its established capability to fulfill specialized pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FQTL0?
SPE2DB26FQTL0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FQTL0 worth?
The government has obligated $20,824 on SPE2DB26FQTL0.
Is contract SPE2DB26FQTL0 an order under another contract?
Yes. SPE2DB26FQTL0 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB26FQTL0 competed?
The extent of competition for SPE2DB26FQTL0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award